Literature DB >> 11952479

Cyclodextrins in eye drop formulations: enhanced topical delivery of corticosteroids to the eye.

Thorsteinn Loftsson1, Einar Stefánsson.   

Abstract

Cyclodextrins are cylindrical oligosaccharides with a lipophilic central cavity and hydrophilic outer surface. They can form water-soluble complexes with lipophilic drugs, which 'hide' in the cavity. Cyclodextrins can be used to form aqueous eye drop solutions with lipophilic drugs, such as steroids and some carbonic anhydrase inhibitors. The cyclodextrins increase the water solubility of the drug, enhance drug absorption into the eye, improve aqueous stability and reduce local irritation. Cyclodextrins are useful excipients in eye drop formulations of various drugs, including steroids of any kind, carbonic anhydrase inhibitors, pilocarpine, cyclosporins, etc. Their use in ophthalmology has already begun and is likely to expand the selection of drugs available as eye drops. In this paper we review the properties of cyclodextrins and their application in eye drop formulations, of which their use in the formulation of dexamethasone eye drops is an example. Cyclodextrins have been used to formulate eye drops containing corticosteroids, such as dexamethasone, with levels of concentration and ocular absorption which, according to human and animal studies, are many times those seen with presently available formulations. Cyclodextrin-based dexamethasone eye drops are well tolerated in the eye and seem to provide a higher degree of bioavailability and clinical efficiency than the steroid eye drop formulations presently available. Such formulations offer the possibility of once per day application of corticosteroid eye drops after eye surgery, and more intensive topical steroid treatment in severe inflammation. While cyclodextrins have been known for more than a century, their use in ophthalmology is just starting. Cyclodextrins are useful excipients in eye drop formulations for a variety of lipophilic drugs. They will facilitate eye drop formulations for drugs that otherwise might not be available for topical use, while improving absorption and stability and decreasing local irritation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11952479     DOI: 10.1034/j.1600-0420.2002.800205.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  24 in total

1.  Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.

Authors:  Ketan Hippalgaonkar; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

2.  Effect of ion pairing on in vitro transcorneal permeability of a Δ(9) -tetrahydrocannabinol prodrug: potential in glaucoma therapy.

Authors:  Tushar Hingorani; Waseem Gul; Mahmoud Elsohly; Michael A Repka; Soumyajit Majumdar
Journal:  J Pharm Sci       Date:  2011-10-11       Impact factor: 3.534

3.  Development and clinical evaluation of clotrimazole-β-cyclodextrin eyedrops for the treatment of fungal keratitis.

Authors:  Bazigha K Abdul Rasool; Hiba M Salmo
Journal:  AAPS PharmSciTech       Date:  2012-06-14       Impact factor: 3.246

4.  Passive and oxymetazoline-enhanced delivery with a lens device: pharmacokinetics and efficacy studies with rabbits.

Authors:  David J Miller; S Kevin Li; Anthony L Tuitupou; Rajan P Kochambilli; Kongnara Papangkorn; Donald C Mix; William I Higuchi; John W Higuchi
Journal:  J Ocul Pharmacol Ther       Date:  2008-08       Impact factor: 2.671

5.  Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation.

Authors:  Ketan Hippalgaonkar; Goutham R Adelli; Kanchan Hippalgaonkar; Michael A Repka; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2013-02-19       Impact factor: 2.671

Review 6.  Clinical Applications of Dexamethasone for Aged Eyes.

Authors:  Beatriz Abadia; Pilar Calvo; Antonio Ferreras; Fran Bartol; Guayente Verdes; Luis Pablo
Journal:  Drugs Aging       Date:  2016-09       Impact factor: 3.923

7.  Electrospinning of dexamethasone/cyclodextrin inclusion complex polymer fibers for dental pulp therapy.

Authors:  Arwa Daghrery; Zeynep Aytac; Nileshkumar Dubey; Ling Mei; Anna Schwendeman; Marco C Bottino
Journal:  Colloids Surf B Biointerfaces       Date:  2020-04-07       Impact factor: 5.268

8.  Transcorneal permeation in a corneal device of non-steroidal anti-inflammatory drugs in drug delivery systems.

Authors:  R Valls; E Vega; M L Garcia; M A Egea; J O Valls
Journal:  Open Med Chem J       Date:  2008-05-22

9.  Bio-Distribution and Pharmacokinetics of Topically Administered γ-Cyclodextrin Based Eye Drops in Rabbits.

Authors:  Martin Kallab; Kornelia Schuetzenberger; Nikolaus Hommer; Bhavapriya Jasmin Schäfer; Doreen Schmidl; Helga Bergmeister; Markus Zeitlinger; Aimin Tan; Phatsawee Jansook; Thorsteinn Loftsson; Einar Stefansson; Gerhard Garhöfer
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-18

10.  Evaluation of cyclodextrins for enhancing corneal penetration of natamycin eye drops.

Authors:  Anjali Badhani; Prashant Dabral; Vinod Rana; Kumud Upadhyaya
Journal:  J Pharm Bioallied Sci       Date:  2012-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.